Case | Diagnosis | Age (years) | Gender | Indication for LT | Weight (g) | CIT (min) | Viability (%) | Yield (× 106/g) |
---|---|---|---|---|---|---|---|---|
ZXT | OTCD | 4 | Female | Recurrent hyperammonemia | 154 | 269 | 54 | 14.50 |
LXY | MMA | 2 | Male | Recurrent metabolic decompensations | 111 | 390 | 96 | 13.33 |
XCL | Argininemia | 13 | Male | Recurrent hyperammonemia and neurological damage | 321 | 197 | 86 | 6.12 |
LHZ | OTCD | 1 | Male | Recurrent hyperammonemia | 108 | 208 | 96 | 13.42 |
AJX | Citrullinemia | 1 | Female | Recurrent hyperammonemia | 158 | 224 | 92 | 7.94 |
WYH | PA | 2 | Male | Recurrent metabolic decompensations | 169 | 432 | 89 | 8.85 |
ZYX | Citrullinemia | 6 | Male | Recurrent hyperammonemia and neurological damage | 172 | 268 | 91 | 7.01 |
ZJN | OTCD | 2 | Female | Recurrent hyperammonemia and liver function impairment | 134 | 221 | 94 | 9.07 |
HXW | Argininemia | 2 | Female | Neurological damage | 132 | 303 | 81 | 4.43 |
LJ | FH | 5 | Male | Severe atherosclerosis refractory to medical therapy | 194 | 243 | 74 | 7.32 |